Ultracol, the world’s first microsphere bio-stimulator based on polydioxanone (PDO), has quickly become world renowned amongst doctors and patients alike due to its unique, patented and certified technology.
Ultra V is a renowned South Korean company that develops, manufactures, and supplies medical devices and functional cosmetics to domestic and overseas markets. It also manufactures polydioxanone (PDO) and polycaprolactone (PCL) for use in dermatology and plastic surgery through its global distribution network in 60 countries.
“The combination of innovation and extensive experience enables us to provide safe, powerful and cutting-edge products in the field of medical aesthetics,” says Dr. Kwon Han Jin, CEO of Ultra V. “Our focus is the constant development and improvement of treatment methods in thread lifting, mesotherapy and dermal fillers. Due to our highly skilled team of medical doctors, instructors and employees, we can provide unique products of excellent quality, and up-to-date hands-on training for doctors, natural practitioners, medical practices and clinics worldwide.”
The lifting threads, dermal filler and mesotherapy boosters made by Ultra V are among the safest and most innovative products on the global market today, whilst the company’s PDO, PCL, PLCL lifting threads, fillers and boosters are used for applications such as facial and eyebrow lifting, wrinkle reduction, skin tightening, skin radiance and other corporeal aesthetic treatments.
Its new Ultracol product, the world’s first microsphere bio-stimulator based on polydioxanone
–commonly known as PDO –has quickly become most widely associated with Ultra V due to its unique, patented and certified technology.
“Ultracol is an effective collagen stimulator and highly suited for difficult indications such as the glabella, dark circles and wrinkles in the undereye area,” says Dr. Kwon. “Despite the relatively short time in the market, Ultracol has already created a significantsensation,asdoctorsrecognizeitsunique benefits. Our enhancement of this technology lies in the particle shape of Ultracol, afine round shape that achieved a Korean patent for its production technology. Thanks to this shape, the side effect of this product is significantly lower than other fillers that have irregular-shaped particles. Fortunately, Ultracol was approved by the KFDA in2016 andso far it has been approved by 19 countries, including China (in Hainan Province), and many European, South American and Asian countries.”
Because PDO has been safely used for synthetic sutures for 60 years, doc
